What is the recommended additional dose of insulin lispro (insulin lispro) after an initial dose of 22 units on a sliding scale?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Additional Insulin Lispro Dosing After 22-Unit Sliding Scale

After administering 22 units of insulin lispro on a sliding scale, no additional correction dose should be given at that time—instead, reassess blood glucose in 1-2 hours when lispro peaks, and only then consider further correction if hyperglycemia persists. 1

Immediate Management

The 22-unit dose already represents a substantial correction for severe hyperglycemia. Adding more insulin immediately risks:

  • Insulin stacking, where overlapping insulin action causes severe hypoglycemia 1, 2
  • Peak action occurs 1-2 hours post-injection for rapid-acting insulin lispro, meaning the full effect hasn't yet manifested 3, 4

When to Consider Additional Insulin

If reassessing 2-4 hours after the initial dose:

  • For glucose >250 mg/dL but <350 mg/dL: Give 2 units of insulin lispro 1, 2
  • For glucose >350 mg/dL: Give 4 units of insulin lispro 1, 2

These simplified sliding scale recommendations from the American Diabetes Association are intended for temporary use only while adjusting the underlying insulin regimen. 1

Critical Action: Fix the Underlying Problem

A 22-unit correction dose signals that the basal insulin regimen is inadequate. 2, 3

The need for such large correction doses daily indicates you should:

  • Increase basal insulin by 2 units every 3-7 days until fasting glucose reaches 90-150 mg/dL 2, 3
  • Stop using sliding scale when not needed daily—this approach should only be temporary 1, 2
  • Consider that 50-70% of total daily insulin should be basal in most patients 1

Safety Monitoring

Monitor for hypoglycemia 1-2 hours post-injection when lispro action peaks, particularly in patients with: 2, 3

  • Impaired renal function (insulin clearance is reduced) 2
  • Concurrent sulfonylurea use (additive hypoglycemia risk) 2
  • Older adults or those with cognitive impairment 1

Never administer rapid-acting insulin at bedtime due to nocturnal hypoglycemia risk. 1, 3

Timing Considerations for Future Doses

For hyperglycemic patients (glucose >180 mg/dL), inject lispro 15 minutes before the meal rather than immediately before eating, as this timing improves postprandial glucose control. 5 However, injecting 30 minutes before meals may cause late hypoglycemia in some patients. 5

Common Pitfalls to Avoid

  • Giving correction insulin too frequently (more often than every 4 hours for lispro) leads to insulin stacking 1, 2
  • Failing to address inadequate basal insulin when correction doses are needed daily 2, 3
  • Using sliding scales as a long-term strategy rather than a temporary bridge while optimizing the regimen 1, 2
  • Not accounting for lispro's 3-4 hour duration of action when calculating subsequent doses 3, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insulin Dosing for Hyperglycemia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Insulin Lispro Administration and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The human insulin analogue insulin lispro.

Annals of medicine, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.